Andrew M Creighton

Title: Andrew M Creighton: Innovator in Peptide Technology

Introduction

Andrew M Creighton is a notable inventor based in Mill Hill, London, GB. He has made significant contributions to the field of peptide technology, particularly in the development of methods that enhance diagnostic capabilities in medical applications.

Latest Patents

Andrew M Creighton holds a patent for "Peptides which serve as substrates for a phosphokinase and methods for attaching .sup.32 P to a protein." This innovative method involves the introduction of a peptide region to a protein, typically an antibody, which binds to and irradiates tumor-associated structures, leading to diagnostic benefits. The invention utilizes .sup.32 P-.gamma.-ATP as a source of the radionuclide, and the conjugation of the substrate molecule to the protein can be achieved through chemical methods or genetic engineering techniques. This patent highlights his expertise in creating novel substrate peptides.

Career Highlights

Throughout his career, Andrew has focused on advancing peptide technology and its applications in diagnostics. His work has contributed to the understanding of how peptides can be utilized in medical research and treatment.

Collaborations

Andrew has collaborated with notable professionals in his field, including Brian Maurice Foxwell and Peter H Parker. These collaborations have further enriched his research and development efforts.

Conclusion

Andrew M Creighton is a distinguished inventor whose work in peptide technology has the potential to significantly impact medical diagnostics. His innovative approaches and collaborations continue to drive advancements in this important field.